Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ATPC | Agape Atp | $4.02 | $2.00 | 98.94% | 51.3M | $2.0M | $1.72$128.25 |
| ACXP | Acurx Pharmaceuticals | $2.75 | $0.80 | 40.67% | 22M | $5.0M | $1.33$21.00 |
| MGNX | MacroGenics | $3.02 | $0.66 | 27.75% | 133.2K | $149M | $0.99$3.11 |
| TTEC | TTEC Holdings | $3.15 | $0.66 | 26.32% | 1.2M | $121M | $1.98$5.60 |
| INKT | MiNK Therapeutics | $12.93 | $2.48 | 23.73% | 226.9K | $49M | $6.34$76.00 |
| PIII | P3 Health Partners | $3.56 | $0.68 | 23.40% | 259.2K | $9.5M | $1.52$11.30 |
| AGCC | Agencia Comercial Spirits | $22.19 | $3.99 | 21.92% | 134.6K | $626M | $3.66$24.98 |
| IXHL | Incannex Healthcare | $5.10 | $0.87 | 20.57% | 31.8K | $49M | $2.40$49.80 |
| LFMD | LifeMD | $3.76 | $0.64 | 20.51% | 74.2K | $150M | $2.56$15.84 |
| PLYX | Polaryx Therapeutics | $4.24 | $0.72 | 20.45% | 378.8K | $167M | $2.20$48.91 |
| CRMU | Themes ETF Trust - Leverage Shares 2x Long Crml Daily ETF | $9.14 | $1.54 | 20.29% | 33.3K | - | $6.52$15.25 |
| ZVRA | Zevra Therapeutics | $10.96 | $1.84 | 20.12% | 5.9M | $513M | $6.19$13.16 |
| OCC | Optical Cable | $7.32 | $1.21 | 19.80% | 351.3K | $54M | $2.40$11.50 |
| AXTI | AXT | $46.15 | $7.59 | 19.68% | 397.8K | $2.1B | $1.13$47.03 |
| GEMG | Themes ETF Trust - Leverage Shares 2x Long Gemi Daily ETF | $3.00 | $0.47 | 18.63% | 48.8K | - | $1.13$17.73 |
| TENX | Tenax Therapeutics | $13.00 | $1.98 | 17.97% | 19.6K | $69M | $4.63$18.38 |
| FGI | Fgi Industries | $4.01 | $0.60 | 17.66% | 6.2K | $6.5M | $2.28$12.62 |
| TKNO | Alpha Teknova | $2.47 | $0.35 | 16.51% | 7.6K | $114M | $1.91$7.48 |
| VYGR | Voyager Therapeutics | $4.75 | $0.64 | 15.45% | 2.6M | $229M | $2.65$5.55 |
| CAPR | Capricor Therapeutics | $35.16 | $4.53 | 14.79% | 2.9M | $1.7B | $4.30$40.37 |
| FUTG | Themes ETF Trust - Leverage Shares 2x Long Futu Daily ETF | $11.70 | $1.48 | 14.48% | 109.8K | - | $9.46$22.90 |
| PEPG | PepGen | $6.36 | $0.79 | 14.18% | 277.1K | $385M | $0.88$7.80 |
| FIGR | Figure Technology Solutions | $37.16 | $4.52 | 13.85% | 799.1K | $7.0B | $25.00$78.00 |
| QUIK | QuickLogic | $9.72 | $1.15 | 13.42% | 12K | $146M | $4.26$9.74 |
| YHGJ | Yunhong Green Cti | $3.05 | $0.27 | 9.53% | 12.8K | $7.7M | $2.38$11.50 |
| APPX | Investment Managers Series Trust II - Tradr 2x Long App Daily ETF | $41.18 | -$6.97 | -14.48% | 461.9K | - | $20.21$157.62 |
Related Articles
Featured Article
Here's Why This Biotechnology Skyrocketed by 439% in December
Lee Samaha|Jan 9, 2026
A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an exciting new treatment.
1 Small-Cap Stock I'd Buy Before GLBE in 2026
Marc Guberti|Jan 8, 2026
Global-E Online is a small company trying to carve out a niche in the competitive e-commerce space, while AXT is a small semiconductor player that already has a lead in an emerging opportunity.
2 Biotech Stocks That Could Make You Richer
James Halley|Jul 14, 2023
These biotech companies are seeing a spike in revenue growth.
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
Keith Speights|Mar 19, 2022
Voyager Therapeutics has promising technology. But the stock is very risky.
Parkinson's Disease Patients Get Long-Term Benefits From Experimental Gene Therapy
Cory Renauer|Sep 11, 2020
Three years after treatment with NBIb-1817, Parkinson's disease patients still are still showing improvements.
Is Now a Good Time To Buy Neurocrine Biosciences?
James Halley|May 14, 2020
The biopharmaceutical company has seen shares rise 44.5% in less than two months.
3 Small-Cap Biotech Stocks That Surged Last Week
Cory Renauer|May 11, 2020
Here's what's behind their impressive market performances.
4 Stocks Battling Breast Cancer
David Haen|Oct 26, 2019
With Breast Cancer Awareness Month drawing to a close and the San Antonio Breast Cancer Symposium on the horizon, stay alert for breaking news from companies developing new treatments.
3 Biotechs That Have Doubled This Year (Acquisition Next?)
Brian Orelli, PhD|Jul 2, 2019
Good news has a way of attracting suitors.
3 Cancer Treatment Stocks to Buy Right Now
Keith Speights, Chuck Saletta, and Todd Campbell|May 23, 2019
These companies could make a big difference in how the disease is diagnosed and treated. And their stocks could make a big difference for long-term investors.
